These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 2659296

  • 1. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
    Rivera-Vazquez CR, Ramirez-Ronda CH, Rodriguez JR, Saavedra S.
    Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.
    Rodríguez JR, Ramírez-Ronda CH, Nevárez M.
    Antimicrob Agents Chemother; 1985 Feb; 27(2):246-51. PubMed ID: 4039118
    [Abstract] [Full Text] [Related]

  • 3. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
    Birolini D, Moraes MF, de Souza OS.
    Chemotherapy; 1989 Feb; 35 Suppl 1():49-57. PubMed ID: 2659290
    [Abstract] [Full Text] [Related]

  • 4. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections.
    Barboza E, del Castillo M, Yi A, Gotuzzo E.
    Surgery; 1994 Jul; 116(1):28-35. PubMed ID: 8023265
    [Abstract] [Full Text] [Related]

  • 5. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS, Ramirez-Ronda C, Saavedra S, Rivera-Vázquez CR, Liu C, Hinthorn DR.
    Clin Ther; 1993 Jul; 15(1):65-78. PubMed ID: 8458056
    [Abstract] [Full Text] [Related]

  • 6. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli.
    Nolen TM, Phillips HL, Hall HJ.
    Rev Infect Dis; 1985 Jul; 7 Suppl 4():S666-8. PubMed ID: 3909321
    [Abstract] [Full Text] [Related]

  • 7. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
    Birolini D, Moraes MF, de Souza OS.
    Rev Infect Dis; 1985 Jul; 7 Suppl 4():S724-8. PubMed ID: 3909330
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
    Torres A, de Celis R, Rabinad E, Marco F, Almela M, Deulofeu R, Rodriguez-Roisin R, Agusti Vidal A.
    Chemotherapy; 1989 Jul; 35 Suppl 1():15-24. PubMed ID: 2659289
    [Abstract] [Full Text] [Related]

  • 13. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E, Bosch-Perez A.
    Chemotherapy; 1989 Jul; 35 Suppl 1():1-7. PubMed ID: 2659288
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
    Joshi M, Fitzpatrick BJ, Warren JW, Caplan ES, Tenney JH.
    Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders].
    Tsuda S, Tanaka S, Nakagawa H, Nishigaki H, Okuda T, Horiike S, Taniwaki M, Misawa S, Inazawa J, Abe T.
    Jpn J Antibiot; 1989 Sep; 42(9):1926-37. PubMed ID: 2810755
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.